These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25243792)

  • 21. Lineage specific expression of Polycomb Group Proteins in human embryonic stem cells in vitro.
    Pethe P; Pursani V; Bhartiya D
    Cell Biol Int; 2015 May; 39(5):600-10. PubMed ID: 25572667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of EZH2 expression and activity in renal cell carcinoma: a prospective study.
    Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J
    PLoS One; 2013; 8(11):e81484. PubMed ID: 24312307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
    Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
    J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).
    Changchien YC; Tátrai P; Papp G; Sápi J; Fónyad L; Szendrői M; Pápai Z; Sápi Z
    J Transl Med; 2012 Oct; 10():216. PubMed ID: 23110793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance.
    Hinz S; Kempkensteffen C; Christoph F; Krause H; Schrader M; Schostak M; Miller K; Weikert S
    Tumour Biol; 2008; 29(5):323-9. PubMed ID: 18984978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
    Li H; Cai Q; Godwin AK; Zhang R
    Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global changes of H3K27me3 domains and Polycomb group protein distribution in the absence of recruiters Spps or Pho.
    Brown JL; Sun MA; Kassis JA
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):E1839-E1848. PubMed ID: 29432187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
    Holm K; Grabau D; Lövgren K; Aradottir S; Gruvberger-Saal S; Howlin J; Saal LH; Ethier SP; Bendahl PO; Stål O; Malmström P; Fernö M; Rydén L; Hegardt C; Borg Å; Ringnér M
    Mol Oncol; 2012 Oct; 6(5):494-506. PubMed ID: 22766277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer.
    Fornaro L; Faviana P; De Gregorio V; Vivaldi C; Paolicchi E; Masi G; Loupakis F; Sensi E; Lupi C; Fontanini G; Wang Y; Danesi R; Falcone A; Crea F
    BMC Cancer; 2015 Nov; 15():874. PubMed ID: 26553291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas - prognostic biomarkers for routine practice.
    Samal S; Patnaik A; Sahu F; Purkait S
    Folia Neuropathol; 2020; 58(2):133-142. PubMed ID: 32729292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone-modifying genes as biomarkers in hepatocellular carcinoma.
    Hung SY; Lin HH; Yeh KT; Chang JG
    Int J Clin Exp Pathol; 2014; 7(5):2496-507. PubMed ID: 24966962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current understanding of plant Polycomb group proteins and the repressive histone H3 Lysine 27 trimethylation.
    Jiao H; Xie Y; Li Z
    Biochem Soc Trans; 2020 Aug; 48(4):1697-1706. PubMed ID: 32725200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression.
    Gjerstorff MF; Relster MM; Greve KB; Moeller JB; Elias D; Lindgreen JN; Schmidt S; Mollenhauer J; Voldborg B; Pedersen CB; Brückmann NH; Møllegaard NE; Ditzel HJ
    Nucleic Acids Res; 2014 Oct; 42(18):11433-46. PubMed ID: 25249625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
    Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
    Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma.
    Gao SB; Xu B; Ding LH; Zheng QL; Zhang L; Zheng QF; Li SH; Feng ZJ; Wei J; Yin ZY; Hua X; Jin GH
    J Hepatol; 2014 Oct; 61(4):832-9. PubMed ID: 24845612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.
    Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ
    Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The polycomb group protein SUZ12 regulates histone H3 lysine 9 methylation and HP1 alpha distribution.
    de la Cruz CC; Kirmizis A; Simon MD; Isono K; Koseki H; Panning B
    Chromosome Res; 2007; 15(3):299-314. PubMed ID: 17406994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation.
    Rush M; Appanah R; Lee S; Lam LL; Goyal P; Lorincz MC
    Epigenetics; 2009 Aug; 4(6):404-14. PubMed ID: 19717977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.